Literature DB >> 35792970

Nutraceuticals and migraine: further strategy for the treatment of specific conditions.

Simone Quintana1, Marco Russo2, Paola Torelli3.   

Abstract

Nutraceuticals might be defined as food or dietary supplements that provide medicinal or health benefits. Current preventive treatment of migraine includes nutraceuticals as well as conventional drugs. These non-pharmacological therapies, such as magnesium, coenzyme Q10, feverfew, riboflavin, and phycocyanins, are particularly useful in certain categories of patients (adolescents, pregnant or breastfeeding women, the elderly with complex drug therapy, the patient with contraindication to the usual pharmacological therapies) when a conventional drug therapy cannot be prescribed or may be not well tolerated. The evidence currently available confirms a modest efficacy but a very good safety and tolerability profile.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Migraine; Nutraceuticals; Prevention

Year:  2022        PMID: 35792970     DOI: 10.1007/s10072-022-06250-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

2.  A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.

Authors:  Shalonda K Slater; Timothy D Nelson; Marielle A Kabbouche; Susan L LeCates; Paul Horn; Ann Segers; Paula Manning; Scott W Powers; Andrew D Hershey
Journal:  Cephalalgia       Date:  2011-05-17       Impact factor: 6.292

Review 3.  The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview.

Authors:  Qinghua Wu; Lian Liu; Anca Miron; Blanka Klímová; Dan Wan; Kamil Kuča
Journal:  Arch Toxicol       Date:  2016-06-03       Impact factor: 5.153

4.  Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.

Authors:  Samira Khani; Seyed Amir Hejazi; Mehdi Yaghoubi; Ehsan Sharifipour
Journal:  J Headache Pain       Date:  2021-04-07       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.